Raymond James & Associates DOVA PHARMACEUTICALS INC Transaction History

Raymond James & Associates

  • $161 Billion
  • Q3 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 07, 2019
SELL
N/A
-11,974 Closed
0 $0
Q2 2019

Aug 06, 2019
SELL
N/A
-2,879 Reduced 19.38%
11,974 $169,000
Q1 2019

May 06, 2019
SELL
N/A
-7,236 Reduced 32.76%
14,853 $132,000
Q4 2018

Feb 11, 2019
SELL
N/A
-24,050 Reduced 52.13%
22,089 $167,000
Q3 2018

Nov 14, 2018
SELL
N/A
-2,834 Reduced 5.79%
46,139 $968,000
Q2 2018

Aug 14, 2018
BUY
N/A
48,973 New
48,973 $1.47 Million
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email